Thursday, December 15, 2016

BRIEF-Knight Therapeutics announces exclusive license agreement with AstraZeneca

* Knight therapeutics- as per agreement, co will be

responsible for all commercial, regulatory, certain supply chain

activities for movantik in canada, israel

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)